Jay T. Flatley's most recent trade in Rivian Automotive Inc - Ordinary Shares - Class A was a trade of 16,812 Class A Common Stock done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 16,812 | 160,820 | - | 0 | Class A Common Stock | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 6,037 | 16,220 (0%) | 0% | 0 | Common Stock | |
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 24,224 | 144,008 | - | 0 | Class A Common Stock | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 17,901 | 17,901 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,967 | 10,183 (0%) | 0% | 0 | Common Stock | |
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 18,208 | 119,784 | - | 0 | Class A Common Stock | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,649 | 12,649 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 4,216 | 340,529 (0%) | 0% | 0 | Common Stock | |
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 8,960 | 101,576 | - | 0 | Class A Common Stock | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,959 | 17,959 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 5,986 | 336,313 (0%) | 0% | 0 | Common Stock | |
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Purchase of securities on an exchange or from another person at price $ 29.31 per share. | 26 May 2022 | 40,000 | 92,616 | - | 29.3 | 1,172,400 | Class A Common Stock |
| Rivian Automotive Inc (Class A) | Jay T. Flatley | Director | Purchase of securities on an exchange or from another person at price $ 78.00 per share. | 15 Nov 2021 | 20,000 | 52,616 | - | 78 | 1,560,000 | Class A Common Stock |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 6,222 | 6,222 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 2,074 | 330,327 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 3,253 | 328,253 (0%) | 0% | 0 | Common Stock | |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 3,253 | 0 | - | - | Restricted Stock Units | |
| Illumina Inc | Jay T. Flatley | Director | Sale of securities on an exchange or to another person at price $ 379.53 per share. | 18 May 2021 | 4,000 | 148,933 (0%) | 0% | 379.5 | 1,518,120 | Common Stock |
| Illumina Inc | Jay T. Flatley | Director | Sale of securities on an exchange or to another person at price $ 384.15 per share. | 04 May 2021 | 4,000 | 152,933 (0%) | 0% | 384.2 | 1,536,600 | Common Stock |
| Illumina Inc | Jay T. Flatley | Director | Sale of securities on an exchange or to another person at price $ 401.83 per share. | 20 Apr 2021 | 4,000 | 156,933 (0%) | 0% | 401.8 | 1,607,320 | Common Stock |
| Illumina Inc | Jay T. Flatley | Director | Sale of securities on an exchange or to another person at price $ 423.44 per share. | 06 Apr 2021 | 4,000 | 160,933 (0%) | 0% | 423.4 | 1,693,740 | Common Stock |
| Illumina Inc | Jay T. Flatley | Director | Sale of securities on an exchange or to another person at price $ 421.06 per share. | 16 Mar 2021 | 4,000 | 164,933 (0%) | 0% | 421.1 | 1,684,240 | Common Stock |